Gubra A/S (CPH: GUBRA)

Denmark flag Denmark · Delayed Price · Currency is DKK
470.00
0.00 (0.00%)
Oct 3, 2024, 4:59 PM CET
335.35%
Market Cap 7.66B
Revenue (ttm) 223.82M
Net Income (ttm) -46.53M
Shares Out 16.31M
EPS (ttm) -2.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,318
Open 465.00
Previous Close 470.00
Day's Range 455.00 - 484.00
52-Week Range 90.09 - 754.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 28, 2025

About Gubra

Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs in Denmark and internationally. The company operates through CRO, Discovery & Partnerships, and Gubra Green segments. It offers pre-clinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, assays and molecular pharmacology, bioinformat... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 220
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol GUBRA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.